You just read:

Araim Pharmaceuticals Receives Orphan Drug Designation from the US FDA for ARA 290 for the Treatment of Sarcoidosis

News provided by

Araim Pharmaceuticals, Inc.

Jul 05, 2016, 01:00 ET